Boosting Their Generic Dosage

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Brand loyalty looks increasingly anemic in the prescription-drug sector. Comparison of a pair of Harris Polls — one released last week and one conducted in October 2006 — makes this clear. Each survey asked people who buy prescription drugs to say how often (if they had a choice in the matter) they’d prefer a brand-name drug to the generic alternative, or vice versa. In the new survey (fielded in December), 40 percent said they’d “always” choose the generic — up from 23 percent saying so in the 2006 poll.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in